North America Dermal Fillers Market size surpassed USD 1.9 billion in 2021 and is expected to witness 9.2% CAGR from 2022 to 2028.

A robust product pipeline with potentially effective therapies catering to a wide range of cosmetic procedures will drive the market growth. Regulatory approvals for innovative dermal fillers products will positively influence the industry demand.

Get more details on this report - Request Free Sample PDF

Various companies such as Galderma launched Restylane Kysse, a new hyaluronic acid dermal filler for areas around lips and wrinkles. Also, Revance launched Teoxane Resilient Hyaluronic RHA fillers, for wrinkles and folds. Such advanced products with latest formulation attract more patients. Since these newly developed dermal fillers formulae are easily accessible, the demand for less invasive facial procedure has continued to grow over the years. Furthermore, because of the minimum side effects, there is an increasing demand for cosmetic procedures in developed countries.

As per the American Society of Plastic Surgeons, more than 3.4 million procedures of soft tissue fillers were performed in the U.S. alone in the year 2020. Increased access to information through internet and paid promotions by the companies are leading factors for high procedure rate in the North America. As per a survey, the public believes that media outlets such as magazines, websites, social media encourage young people to resemble the appearance of individuals they admire in order to emulate the lifestyle they suppose celebrities enjoy on a daily basis. The influence of social media on the rise of plastic surgery among teenagers have become a topic of concern globally. The rapid advancement in science and technology has made global communication much easier in comparison to previous years. Celebrities reach out to their fans through social media platforms, leading to rise in plastic surgery among teenagers

North America Market, By Type

The biodegradable dermal fillers market in North America held over 98% revenue share in 2021, due to several benefits provided by biodegradable materials such as polylactic acid, non-toxicity, and a longer material shelf life. According to the American Society of Plastic Surgeons' Plastic Surgery Statistics, more than 130,000 polylactic acid minimally invasive treatments were performed in 2020 in the U.S. As a result, increased procedural volume and product benefits will fuel the market expansion.

North America Dermal Fillers Market, By Material Type

The hyaluronic acid segment accounted for USD 1.7 billion revenue in 2021. The widespread use of hyaluronic acid fillers in treatment of skin ageing will propel the market size. Customers and dermatologists prefer HA because of its effectiveness in reducing the natural ageing process. Growing facial rejuvenation procedures that have resulted in an exponential increase in product demand.

North America Market, By Application

Get more details on this report - Request Free Sample PDF

The facial line correction segment revenue in the North America dermal fillers market was around USD 800 million in 2021. Wrinkles and skin creases are among the most frequent conditions among adults and elderly. Thus, the expanding geriatric population base will increase demand for wrinkle treatment. Furthermore, UV light exposure, smoking, and a high sugar consumption all contribute to undesired face wrinkles.

North America Dermal Fillers Market, By End-use

The dermatology clinics segment will observe around 9.1% growth rate during the forecast timeline. Dermatological clinics provide specialist services to customers with unique ailments. Expertise in this type of healthcare-setting, as well as well-equipped facilities with advanced technology incorporated, drives segment growth. With increasing prevalence of skin disorders and expanding network of dermatological clinics, the segment will continue to rise.

North America Market, By Country

U.S. dermal fillers market size crossed USD 1.7 billion in 2021, attributed to availability of advanced healthcare settings in the country along with increased product demand with procedural volume. Some of the major drivers includes increased out-of-pocket spending, knowledge, an emphasis on facial aesthetics, and a preference for minimally invasive procedures. Furthermore, the presence of a large network of treatment facilities and qualified plastic surgeons will boost the market revenue.

Competitive Industry Landscape

Notable players involved in the North America dermal fillers market include Merz Pharma GmbH & Co. KGaA, Allergan Plc. (AbbVie), Prollenium Medica Technologies, Sinclair Pharma, and Galderma among.

These companies are undertaking numerous growth strategies such as collaborations, partnerships, acquisitions, and product launches to gain competitive edge over others. For instance, in February 2021, Sinclair Pharma launched Lanluma, a novel bio stimulating Poly-L-lactic acid dermal filler for cosmetic procedures. This product launch benefitted the company in developing strong product portfolio and established a competitive advantage over other players.